FRx editorial library
Canadian pharmacy billing guides
The guide library explains recurring claim adjudication problems in a readable format. It is maintained separately from the lookup tool so readers can learn the workflow while pharmacy staff still have a fast lookup interface.
A pharmacist’s framework for rejection-code triage
A field guide for reading Canadian pharmacy claim rejections before calling the help desk or applying an intervention code.Carrier IDs, groups, certificates, issue numbers, and BINs are not the same thing
How to separate the identifiers on a Canadian pharmacy benefit card and avoid misreading a card field as a billing field.Coordination of benefits: why payer order matters before the drug is even checked
A practical explanation of public-plan first payer rules, private secondary claims, manufacturer cards, and manual coordination gaps.Vacation supply is a day-supply problem before it is a billing problem
How to think through travel dates, medication on hand, public program limits, and documentation before submitting a vacation-supply claim.Trillium and private insurance: why the pharmacy cannot see the whole file
How Trillium Drug Program coordination differs from ordinary point-of-sale secondary billing.Intervention codes are professional statements, not payment shortcuts
How to use Canadian pharmacy intervention codes as documented professional declarations rather than trial-and-error overrides.Special authorization, prior authorization, limited use, and exception workflows are not interchangeable
A practical distinction between authorization pathways that are often described with the same shorthand at the counter.Public plans, private plans, and mixed-benefit cards: a pharmacy billing distinction that changes the claim order
How to classify a payer before deciding whether OHIP+, ODB, NIHB, or a private plan should be primary.Ontario clinical-service PINs are program claims, not ordinary drug claims
How pharmacist clinical-service PINs differ from DIN claims and why eligibility, service context, and documentation drive payment.Glucometer replacement billing: pseudo-DINs, groups, serial numbers, and strip compatibility
How manufacturer-sponsored meter replacement claims are structured and why the strip family matters.Manufacturer savings programs are helpful, but they are not insurance
How loyalty cards, copay cards, and patient support programs fit beside public and private coverage.ODB price-ratio flags show ingredient-cost asymmetry, not therapeutic interchangeability
How to interpret a price-ratio list without turning a cost observation into a clinical recommendation.Audit-ready pharmacy notes: what to record before the claim disappears into history
A practical note-writing guide for pharmacy billing decisions that may be reviewed later.How FRx decides whether a source is strong enough to publish
The editorial method used to separate primary-source material from field notes and unverified workflow tips.A glossary for Canadian pharmacy billing conversations
Plain-language definitions for the claim, plan, code, and documentation terms used throughout FRx.Large claim splitting: why high-cost drugs create special billing risk
How single-claim dollar limits and split billing should be documented for expensive medications.Nutritional product claims: the form, UPC, and product name must all agree
Why public nutritional product claims fail when the product identifier does not match the approved entry.Early refill rules: dose change, loss, synchronization, travel, and abuse risk are different stories
How to classify early-refill scenarios before selecting a code or calling the plan.How to use FRx safely at the pharmacy counter
A practical guide to using the FRx lookup tool as a reference without letting a quick answer replace professional verification.Public health medication programs sit outside ordinary claim adjudication
Why some publicly supplied medications are not solved by insurance cards or pharmacy benefit billing.When to stop resubmitting and call the plan
A decision guide for recognizing when a pharmacy-side correction is no longer the best next step.How the FRx lookup tool and the guide library work together
A walkthrough of the public content layer and the professional lookup tool.
A field guide for reading Canadian pharmacy claim rejections before calling the help desk or applying an intervention code.Carrier IDs, groups, certificates, issue numbers, and BINs are not the same thing
How to separate the identifiers on a Canadian pharmacy benefit card and avoid misreading a card field as a billing field.Coordination of benefits: why payer order matters before the drug is even checked
A practical explanation of public-plan first payer rules, private secondary claims, manufacturer cards, and manual coordination gaps.Vacation supply is a day-supply problem before it is a billing problem
How to think through travel dates, medication on hand, public program limits, and documentation before submitting a vacation-supply claim.Trillium and private insurance: why the pharmacy cannot see the whole file
How Trillium Drug Program coordination differs from ordinary point-of-sale secondary billing.Intervention codes are professional statements, not payment shortcuts
How to use Canadian pharmacy intervention codes as documented professional declarations rather than trial-and-error overrides.Special authorization, prior authorization, limited use, and exception workflows are not interchangeable
A practical distinction between authorization pathways that are often described with the same shorthand at the counter.Public plans, private plans, and mixed-benefit cards: a pharmacy billing distinction that changes the claim order
How to classify a payer before deciding whether OHIP+, ODB, NIHB, or a private plan should be primary.Ontario clinical-service PINs are program claims, not ordinary drug claims
How pharmacist clinical-service PINs differ from DIN claims and why eligibility, service context, and documentation drive payment.Glucometer replacement billing: pseudo-DINs, groups, serial numbers, and strip compatibility
How manufacturer-sponsored meter replacement claims are structured and why the strip family matters.Manufacturer savings programs are helpful, but they are not insurance
How loyalty cards, copay cards, and patient support programs fit beside public and private coverage.ODB price-ratio flags show ingredient-cost asymmetry, not therapeutic interchangeability
How to interpret a price-ratio list without turning a cost observation into a clinical recommendation.Audit-ready pharmacy notes: what to record before the claim disappears into history
A practical note-writing guide for pharmacy billing decisions that may be reviewed later.How FRx decides whether a source is strong enough to publish
The editorial method used to separate primary-source material from field notes and unverified workflow tips.A glossary for Canadian pharmacy billing conversations
Plain-language definitions for the claim, plan, code, and documentation terms used throughout FRx.Large claim splitting: why high-cost drugs create special billing risk
How single-claim dollar limits and split billing should be documented for expensive medications.Nutritional product claims: the form, UPC, and product name must all agree
Why public nutritional product claims fail when the product identifier does not match the approved entry.Early refill rules: dose change, loss, synchronization, travel, and abuse risk are different stories
How to classify early-refill scenarios before selecting a code or calling the plan.How to use FRx safely at the pharmacy counter
A practical guide to using the FRx lookup tool as a reference without letting a quick answer replace professional verification.Public health medication programs sit outside ordinary claim adjudication
Why some publicly supplied medications are not solved by insurance cards or pharmacy benefit billing.When to stop resubmitting and call the plan
A decision guide for recognizing when a pharmacy-side correction is no longer the best next step.How the FRx lookup tool and the guide library work together
A walkthrough of the public content layer and the professional lookup tool.